TIBER CREEK GROUP for CIGNA CORPORATION AND SUBSIDIARIES
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Proposals impacting Medicare Advantage and Medicare Part D; Inflation Reduction Act of 2022 (PL 117-169); Issues related pharmacy and prescription drug pricing policy; Issues related to the Advance Notice of Methodological Changes for Calendar Year (CY) 2024 for Medicare Advantage (MA) Capitation Rates and Part C and Part D Payment Policies.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JAMES HEIMBACH | — |
| ANDREW MCKECHNIE | — |
| TIMOTHY ROBINSON | — |
| JOHN KIRKLAND TWOMEY | — |
Health Issues HCR
Issues related to insurance coverage, prescription drugs, pharmacy policy, telemedicine, mental health care, and employer sponsored insurance.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JAMES HEIMBACH | — |
| ANDREW MCKECHNIE | — |
| TIMOTHY ROBINSON | — |
| JOHN KIRKLAND TWOMEY | — |
Defense DEF
Pharmacy issues related to TRICARE and the Fiscal Year 2024 National Defense Authorization Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JAMES HEIMBACH | — |
| ANDREW MCKECHNIE | — |
| TIMOTHY ROBINSON | — |
| JOHN KIRKLAND TWOMEY | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.